Search - tctmd.com

Displaying 201 - 220 of 436

Sort: Relevancy | Date

News Conference News

ACC, EHRA Cancel 2020 Meetings Over COVID-19

Michael O'Riordan

March 09, 2020

News Conference News CRT 2020

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Michael O'Riordan

February 25, 2020

News Daily News

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

Todd Neale

January 23, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Features

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Caitlin E. Cox

December 17, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Industry News

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

October 09, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Daily News

Plateau Seen in Women Pursuing Cardiology Training

Yael L. Maxwell

September 23, 2019

News Daily News

American College of Cardiology Steps Up: Equal Pay, Opportunities for All

Caitlin E. Cox

September 17, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Opinion Off Script

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

Mamas Mamas, BMBCh

August 23, 2019

News Industry News

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

July 11, 2019

News Industry News

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

June 26, 2019

News Conference News TVT 2019

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

Shelley Wood

June 14, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2019

Caitlin E. Cox

May 31, 2019

News Conference News EuroPCR 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Michael O'Riordan

May 27, 2019

News Conference News EuroPCR 2019

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Caitlin E. Cox

May 23, 2019

Advertisement

ACC, EHRA Cancel 2020 Meetings Over COVID-19

PCI-Related MIs Not Linked to Mortality at 1 Year: Onyx ONE

Overuse of CT Scans for Suspected Pulmonary Embolism Persists

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Year in Review: Payment Fights, Wearables, Burnout Defined Cardiology Practice in 2019

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Two-year data shows trend towards lower target vessel failure with Indian stent Supraflex vs. Xience stent from Abbott

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

Plateau Seen in Women Pursuing Cardiology Training

American College of Cardiology Steps Up: Equal Pay, Opportunities for All

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

#Selfies, Carrots, and Push-ups: A Defense of Social Media in Modern-Day Medicine

SMT Announces CE* Mark for the Most Deliverable Stent Supraflex Cruz

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback

TCTMD’s Top 10 Most Popular Stories for May 2019

Daring to Dream: New BRS Data Hint at Low MACE Rates at 2 and 3 Years

Firehawk Stent Still Holds Up Well to Xience at 2 Years: TARGET All Comers

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content